Inhibrx Biosciences stockINBX
Inhibrx Biosciences trades at $80.28, 48.3% below its 52-week high (Apr 22, 2026). The price is below its 50- and 200-day averages, a downtrend. +1.6% year to date, −2.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 13, 2026.
Ratings, candles, signals and the screener for INBX — after you log in
Open the terminalFrequently asked questions about Inhibrx Biosciences
What is the Inhibrx Biosciences stock price?
At the close on Nov 5, 2026: $80.28 (−7.47% on the day). 52-week high: $155.29 on Apr 22, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Inhibrx Biosciences report earnings?
The next quarterly report is on Nov 13, 2026. Last quarter, earnings per share changed −26% year over year, revenue −100%.
Does Inhibrx Biosciences pay dividends?
No, Inhibrx Biosciences does not pay dividends.
Where does Inhibrx Biosciences trade and how to buy it?
Ticker INBX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Inhibrx Biosciences now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for INBX are in the terminal after you log in.